Maravai LifeSciences Holdings, Inc. MRVI
6.98 USD -0.74 (-9.59%)
At closeNov 5, 2026, 4:00 PM EST
6.98 0.00 0.00%
After hours · Nov 5, 4:00 PM ET
6.80 Day range 7.57
2.55 52-week range 9.42
- YTD
- +114.77%
- 1 year
- +143.21%
Financial health
Altman Z-Score
5.35 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -3.6×
FY 2018 5y median -3.6× FY 2025
P/S 2.5×
FY 2018 5y median 2.9× FY 2025
P/B 2.2×
FY 2018 5y median 2.3× FY 2025
P/FCF -6.7×
FY 2018 5y median 3.6× FY 2025
EV/EBITDA -4.9×
FY 2018 5y median 2.4× FY 2025
EV/Sales 3.9×
FY 2018 5y median 5.7× FY 2025
FCF Yield -15.0%
FY 2018 5y median 7.0% FY 2025
Profitability
Gross Margin 18.0%
FY 2018 5y median 48.5% FY 2025
Operating Margin -3.6%
FY 2018 5y median -3.6% FY 2025
Net Margin -70.4%
FY 2018 5y median -41.2% FY 2025
ROE -61.6%
FY 2018 5y median -28.6% FY 2025
ROIC -0.9%
FY 2018 5y median 0.5% FY 2025
ROA -17.0%
FY 2018 5y median -8.0% FY 2025
Growth (YoY)
Revenue -28.3%
FY 2018 FY 2025
Operating Income 97.1%
FY 2018 FY 2025
EPS (diluted) 13.3%
FY 2018 FY 2025
Free Cash Flow -218.7%
FY 2018 FY 2025
Financial Health
Current Ratio 6.6×
FY 2018 5y median 7.7× FY 2025
Quick Ratio 5.7×
FY 2018 5y median 7.3× FY 2025
Debt / Equity 0.2×
FY 2018 5y median 1.2× FY 2025
Net Debt / EBITDA 1.2×
FY 2018 5y median 0.0× FY 2025
Interest Coverage -0.2×
FY 2018 5y median -0.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31